| 产品详情 |
| Edit |   |
|---|
| Product Name | Zotarolimus ≥98% |
|---|
| Description | Purity ~98% by HPLC. Zotarolimus (also known as ABT-578) is an analogue of rapamycin (sirolimus) that was designed to have a shorter in vivo half-life than rapamycin. Zotarolimus was found to be comparable in potency for inhibiting in vitro proliferation of both rat and human T cells and mechanistically similar to sirolimus in having high-affinity binding to the immunophilin FKBP12. Zotarolimus is a semi-synthetic derivative of rapamycin. It was designed for use in stents with phosphorylcholine as a carrier. Solubility: Soluble in DMSO |
|---|
| Size | 1mg, 5mg |
|---|
| Concentration | n/a |
|---|
| Applications | n/a |
|---|
| Other Names | 40-epi-(N1-Tetrazolyl)-rapamycin; ABT-578; KY 12420 |
|---|
| Gene, Accession, CAS # | n/a |
|---|
| Catalog # | Z0818 |
|---|
| Price | |
|---|
| Order / More Info | Zotarolimus ≥98% from UNITED STATES BIOLOGICAL |
|---|
| Product Specific References | n/a |
|---|
| 产品资料 |
|
|